We are live on ! Find out more
PARN

Parnell Pharmaceuticals Holdings Ltd
PARN

Delisted

PARN was delisted on the 30th of December, 2016.

Back to rankings

15 hedge funds and large institutions have $22.1M invested in Parnell Pharmaceuticals Holdings Ltd in 2014 Q3 according to their latest regulatory filings, with 12 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,100% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 1

363% more capital invested

Capital invested by funds: $4.76M → $22.1M (+$17.3M)

275% more funds holding

Funds holding: 4 → 15 (+11)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
15
Holders Change
+11
Holders Change %
+275%
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$4.92M
2
BA
BlackRock Advisors
Delaware
+$3.3M
3
AG
Artal Group
Luxembourg
+$3.01M
4
DM
Deerfield Management
New York
+$2.3M
5
BG
BlackRock Group
United Kingdom
+$1.67M

Top Sellers

1
DCM
Driehaus Capital Management
Illinois
-$688K
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$56.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$4.69M +$4.92M +816,051 New
BA
2
BlackRock Advisors
Delaware
$3.15M +$3.3M +547,549 New
AG
3
Artal Group
Luxembourg
$2.88M +$3.01M +500,000 New
DM
4
Deerfield Management
New York
$2.2M +$2.3M +382,645 New
AWMDMG
5
Austin W. Marxe & David M. Greenhouse
New York
$1.79M – – –
BG
6
BlackRock Group
United Kingdom
$1.59M +$1.67M +276,750 New
PA
7
Perceptive Advisors
New York
$1.21M +$1.26M +210,000 New
Alyeska Investment Group
8
Alyeska Investment Group
Illinois
$1.14M -$56.2K -9,337 -5%
D.E. Shaw & Co
9
D.E. Shaw & Co
New York
$876K +$917K +152,295 New
UOC
10
UBS O'Connor
Illinois
$806K +$844K +140,100 New
PAAMCP
11
Pacific Alternative Asset Management Company (PAAMCO)
California
$646K +$677K +112,343 New
BIM
12
BlackRock Investment Management
Delaware
$453K +$475K +78,802 New
PRCM
13
Pine River Capital Management
Minnesota
$424K – – –
Deutsche Bank
14
Deutsche Bank
Germany
$202K +$212K +35,240 New
TRCT
15
Tower Research Capital (TRC)
New York
$9K +$9.22K +1,531 New
DCM
16
Driehaus Capital Management
Illinois
– -$688K -99,663 Closed

PARN Hedge Fund Activity: Q3 2014 in Review

15 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Parnell Pharmaceuticals Holdings Ltd (PARN) for Q3 2014, worth a combined $22.1M — up 363% from $4.76M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new PARN positions and 1 closed out — a net gain of 11 holders — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $4.92M. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $688K sold.

  • 15 institutional investors held Parnell Pharmaceuticals Holdings Ltd (PARN) as of Q3 2014, up from 4 in Q2 2014.
  • Funds reported $22.1M of Parnell Pharmaceuticals Holdings Ltd stock for Q3 2014, up 363% quarter-over-quarter.
  • 12 funds opened new Parnell Pharmaceuticals Holdings Ltd positions in Q3 2014 and 1 closed out, a net change of +11 holders.
  • The largest Parnell Pharmaceuticals Holdings Ltd buyer in Q3 2014 was Fidelity Investments, an estimated $4.92M added.
  • The largest Parnell Pharmaceuticals Holdings Ltd seller in Q3 2014 was Driehaus Capital Management, an estimated $688K sold.

Based on aggregated 13F filings for Q3 2014.